MedTrace Logo

The Triglyceride/Glucose Index and SGLT-2 Inhibitors

NCT05915884 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 55

Last updated 2024-04-26

No results posted yet for this study

Summary

This study was designed to evaluate the change in triglyceride glucose index, one of the atherosclerotic markers, in patients with type 2 DM followed in the Internal Medicine Clinic of Samsun University, Samsun Training, and Research Hospital.

Methods: The data of the patients who were followed up for at least 3 months by making a retrospective file review will be recorded and analyzed. It is planned to start the study following the ethics committee's approval.

Conditions

Interventions

OTHER

SGLT-2 inhibitors

This study is an observational study. It is not planned to do an interventional activity.

Sponsors & Collaborators

  • Samsun Education and Research Hospital

    lead OTHER

Principal Investigators

  • DÜRİYE SILA KARAGÖZ ÖZEN · Samsun Education and Research Hospital

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-10
Primary Completion
2023-10-28
Completion
2024-01-28

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05915884 on ClinicalTrials.gov